Table 1.
Clinical characteristics of the study population (n=47)
| Variables | |
|---|---|
| Age (years) | 58±14 |
| Sex (male:female) | 25:22 |
| Side (right:left) | 15:32 |
| Onset of symptoms (days) | 4.8±6.3 |
| Dizziness (no:yes) | 32:15 |
| Comorbid disease (no:yes) | 16:31 |
| Audiogram of affected ear | |
| Initial PTA (4 FA, dB HL) | 85.3±20.3 |
| Initial word recognition scores (%) | 12.4±25.8 |
| Laboratory data | |
| Random plasma glucose (mg/dL) | 217±92 |
| Glycosylated hemoglobin (%) | 8.2±1.6 |
| Total cholesterol (mg/dL) | 172±32 |
| Neutrophil-to-lymphocyte ratio | 4.49±3.25 |
| Platelet-to-lymphocyte ratio | 158.7±83.5 |
| Lymphocyte-to-monocyte ratio | 10.34±17.16 |
| Fasting glucose level during steroid treatment (mg/dL) | 216±92 |
| Steroid treatment | |
| Systemic steroid only | 16 |
| Systemic steroid+IT injections (sequential) | 6 |
| Systemic steroid+IT injections (simultaneous) | 25 |
| Duration of follow-up (days) | 82±35 |
Continuous variables are presented with mean±standard deviation or n. Comorbid disease included hypertension, cerebrovascular accident, and cardiovascular disease. Mean PTA was calculated for 4 FA. PTA: pure-tone average, 4 FA: four frequencies (0.5, 1, 2, and 4 kHz), IT: intratympanic